37 Results for "

ERBB3/HER3

" in MedChemExpress (MCE) Product Catalog:
Products (37)

37 Results for "ERBB3/HER3" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-100848
CAS No.: 1603845-32-4
Purity:  98.28%
Target:  

EGFR

Research Areas:  

Cancer

TX1-85-1 is an irreversible Her3 (ErbB3) inhibitor with an IC50 of 23 nM. TX1-85-1 is also the first selective Her3 ligand, which forms a covalent bond with Cys721 located in the ATP-binding site of Her3. TX1-85-1 induces partial degradation of Her3 protein and attenuates Her3-dependent signaling .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P99275
CAS No.: 1262787-83-6
Synonyms: AMG-888; U3-1287

Target:  

EGFR Akt ERK PARP Survivin

Research Areas:  

Cancer

Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3. Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR, HER2, HER3, ERK, and AKT. Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70322
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ERBB3; Receptor Protein-Tyrosine Kinase; Prev. LCCS2; P45-SERBB3; HER3; P85-SERBB3; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3; ERBB-3 R31; Tyrosine Kinase-Type Cell Surface Receptor HER3; MDA-BF-1; Human Epidermal Growth Factor Recep
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P99304
CAS No.: 1448327-63-6
Synonyms: Anti-Human ERBB3 Recombinant Antibody

Target:  

EGFR PI3K Akt p38 MAPK

Research Areas:  

Cancer

Lumretuzumab (Anti-Human ERBB3 Recombinant Antibody) is a humanized anti-HER3 (ERBB3) monoclonal antibody. Lumretuzumab effectively inhibits the activity of key oncogenic signaling pathways such as PI3K/AKT and MAPK. Lumretuzumab has been optimized through glycosyl engineering to enhance antibody-dependent cell-mediated cytotoxicity (ADCC). Lumretuzumab can be used to study HER3-positive, HER2-low-expressing solid tumors, especially breast cancer .
loading...
    loading...
Cat. No.: HY-B0426A
CAS No.: 140462-76-6
Synonyms: ALO4943A; KW4679
Olopatadine hydrochloride (ALO4943A; KW4679) is an orally active histamine H1 receptor antagonist and mast cell stabilizer. Olopatadine hydrochloride exerts antiallergic effects by blocking histamine H1 receptor-mediated activities. Olopatadine hydrochloride inhibits exocytosis, chemokine release, F-actin polymerization, CXCL10-induced calcium influx, and T cell chemotactic activity. Olopatadine hydrochloride also reduces the expression levels of CXCR3 on the surface of CD4 + and CD8 + T cells. Olopatadine hydrochloride inhibits scratching behavior, improves dermatitis scores, and suppresses intraepidermal neurite outgrowth. Olopatadine hydrochloride simultaneously decreases the levels of inflammatory markers, growth factors, histamine, and specific IgE, while increasing the expression of ErbB3A/HER3A. Olopatadine hydrochloride can be used in research related to seasonal pollinosis, chronic rhinitis, urticaria, allergic conjunctivitis, alopecia areata, and atopic dermatitis [3].
loading...
    loading...
Cat. No.: HY-W062109
CAS No.: 113806-05-6
Target:  

Histamine Receptor CXCR

Research Areas:  

Inflammation/Immunology

Olopatadine (ALO4943A; KW4679) is an orally active histamine H1 receptor antagonist and mast cell stabilizer. Olopatadine exerts antiallergic effects by blocking histamine H1 receptor-mediated activities. Olopatadine inhibits exocytosis, chemokine release, F-actin polymerization, CXCL10-induced calcium influx, and T cell chemotactic activity. Olopatadine also reduces the expression levels of CXCR3 on the surface of CD4 + and CD8 + T cells. Olopatadine inhibits scratching behavior, improves dermatitis scores, and suppresses intraepidermal neurite outgrowth. Olopatadine simultaneously decreases the levels of inflammatory markers, growth factors, histamine, and specific IgE, while increasing the expression of ErbB3A/HER3A. Olopatadine can be used in research related to seasonal pollinosis, chronic rhinitis, urticaria, allergic conjunctivitis, alopecia areata, and atopic dermatitis [3].
loading...
    loading...
Cat. No.: HY-P991245

Target:  

EGFR

Research Areas:  

Cancer

Anti-ERBB3/HER3 (SGP1) is a human monoclonal antibody (mAb) targeting ERBB3/HER3. Anti-ERBB3/HER3 (SGP1) inhibits Neuregulin stimulated growth of cultured breast cancer cells. Anti-ERBB3/HER3 (SGP1) can be used in breast cancer research .
loading...
    loading...
Cat. No.: HY-P991241

Target:  

EGFR

Research Areas:  

Cancer

Anti-ERBB3/HER3 (29Z6) is an antibody inhibitor, targeting to human ERBB3/HER3.
loading...
    loading...
Cat. No.: HY-P992128
CAS No.: 3059743-20-0
Target:  

EGFR

Research Areas:  

Others

Rinumafusp alfa is a human monoclonal antibody targeting ERBB3/HER3. The corresponding isotype control is: Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-W062109S
CAS No.: 1231979-85-3
Olopatadine-d6 is the deuterium labeled Olopatadine. Olopatadine hydrochloride (ALO4943A; KW4679) is an orally active histamine H1 receptor antagonist and mast cell stabilizer. Olopatadine hydrochloride exerts antiallergic effects by blocking histamine H1 receptor-mediated activities. Olopatadine hydrochloride inhibits exocytosis, chemokine release, F-actin polymerization, CXCL10-induced calcium influx, and T cell chemotactic activity. Olopatadine hydrochloride also reduces the expression levels of CXCR3 on the surface of CD4 + and CD8 + T cells. Olopatadine hydrochloride inhibits scratching behavior, improves dermatitis scores, and suppresses intraepidermal neurite outgrowth. Olopatadine hydrochloride simultaneously decreases the levels of inflammatory markers, growth factors, histamine, and specific IgE, while increasing the expression of ErbB3A/HER3A. Olopatadine hydrochloride can be used in research related to seasonal pollinosis, chronic rhinitis, urticaria, allergic conjunctivitis, alopecia areata, and atopic dermatitis [3].
loading...
    loading...
Cat. No.: HY-P80659
Synonyms: ERBB3; HER3; Receptor tyrosine-protein kinase ERBB-3; Proto-oncogene-like protein c-ERBB-3; Tyrosine kinase-type cell surface receptor HER3

Host:  

Rabbit

Application:  

WB, IHC-P, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P86321
Synonyms: ERBB3; HER3; Receptor tyrosine-protein kinase ERBB-3; Proto-oncogene-like protein c-ERBB-3; Tyrosine kinase-type cell surface receptor HER3

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, ELISA

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P810613
Synonyms: ERBB3; HER3; Receptor tyrosine-protein kinase ERBB-3; Proto-oncogene-like protein c-ERBB-3; Tyrosine kinase-type cell surface receptor HER3

Host:  

Rabbit

Application:  

WB, ICC/IF

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P80659A
Synonyms: ERBB3; HER3; Receptor tyrosine-protein kinase ERBB-3; Proto-oncogene-like protein c-ERBB-3; Tyrosine kinase-type cell surface receptor HER3

Host:  

Rabbit

Application:  

WB, IHC-P, FC

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P810612
Synonyms: ERBB3; HER3; Receptor tyrosine-protein kinase ERBB-3; Proto-oncogene-like protein c-ERBB-3; Tyrosine kinase-type cell surface receptor HER3

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-100848R
CAS No.: 1603845-32-4
Research Areas:  

Cancer

TX1-85-1 (Standard) is the analytical standard of TX1-85-1 (HY-100848). This product is intended for research and analytical applications. TX1-85-1 is an irreversible Her3 (ErbB3) inhibitor with an IC50 of 23 nM. TX1-85-1 is also the first selective Her3 ligand, which forms a covalent bond with Cys721 located in the ATP-binding site of Her3. TX1-85-1 induces partial degradation of Her3 protein and attenuates Her3-dependent signaling .
loading...
    loading...
Cat. No.: HY-P72625
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ERBB3; Receptor Protein-Tyrosine Kinase; Prev. LCCS2; P45-SERBB3; HER3; P85-SERBB3; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3; ERBB-3 R31; Tyrosine Kinase-Type Cell Surface Receptor HER3; MDA-BF-1; Human Epidermal Growth Factor Recep
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P74891
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: ERBB3; Receptor Protein-Tyrosine Kinase; Prev. LCCS2; P45-SERBB3; HER3; P85-SERBB3; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3; ERBB-3 R31; Tyrosine Kinase-Type Cell Surface Receptor HER3; MDA-BF-1; Human Epidermal Growth Factor Recep
Species:  
Rat
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P74892
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: ERBB3; Receptor Protein-Tyrosine Kinase; Prev. LCCS2; P45-SERBB3; HER3; P85-SERBB3; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3; ERBB-3 R31; Tyrosine Kinase-Type Cell Surface Receptor HER3; MDA-BF-1; Human Epidermal Growth Factor Recep
Species:  
Rat
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P76967
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: ERBB3; Receptor Protein-Tyrosine Kinase; Prev. LCCS2; P45-SERBB3; HER3; P85-SERBB3; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 3; ERBB-3 R31; Tyrosine Kinase-Type Cell Surface Receptor HER3; MDA-BF-1; Human Epidermal Growth Factor Recep
Species:  
Rhesus Macaque
Source:  
HEK293
loading...
    loading...